We found that age appears to modify the relationship between these plasma markers and CP integrity, indicating that lower CP structural integrity tended to be associated with higher levels of AD pathology, neurodegeneration and neuroinflammation among old and middle-aged subjects. This evidence concerns the gene CP and Alzheimer disease.